Connor, Clark & Lunn Investment Management Ltd. - MIRATI THERAPEUTICS INC ownership

MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 290 filers reported holding MIRATI THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.6%.

Quarter-by-quarter ownership
Connor, Clark & Lunn Investment Management Ltd. ownership history of MIRATI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,857,790
-56.1%
42,649
-63.6%
0.01%
-52.4%
Q2 2023$4,232,666
-16.6%
117,151
-14.2%
0.02%
-25.0%
Q1 2023$5,074,549
+66.7%
136,486
+557.7%
0.03%
+86.7%
Q4 2021$3,044,000
+299.5%
20,751
+366.5%
0.02%
+275.0%
Q1 2021$762,000
+15.1%
4,448
+47.6%
0.00%0.0%
Q4 2020$662,000
+1041.4%
3,013
-81.1%
0.00%
Q2 2017$58,000
-29.3%
15,900
+0.6%
0.00%
-100.0%
Q1 2017$82,00015,8000.00%
Other shareholders
MIRATI THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Aviva Holdings Ltd. 3,135,966$136,602,67987.83%
EcoR1 Capital, LLC 5,748,399$250,400,2608.45%
Boxer Capital, LLC 3,201,440$139,454,7267.42%
RTW INVESTMENTS, LP 6,768,514$294,836,4706.22%
Paradigm Biocapital Advisors LP 1,668,116$72,663,1334.93%
Avoro Capital Advisors LLC 6,666,666$290,399,9714.53%
Octagon Capital Advisors LP 655,051$28,534,0224.38%
Artal Group S.A. 2,024,226$88,1753.78%
Ally Bridge Group (NY) LLC 70,283$3,061,5273.59%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 216,000$9,404,6403.17%
View complete list of MIRATI THERAPEUTICS INC shareholders